Mersana Therapeutics Announces Initiation of the UPGRADE Phase 1 Platinum Combination Cohort for UpRi in Platinum-Sensitive Ovarian Cancer
UPGRADE umbrella study designed to evaluate UpRi in combination with other therapies, starting with carboplatinCAMBRIDGE, Mass.,…




